See more : Intercontinental Exchange, Inc. (ICE) Income Statement Analysis – Financial Results
Complete financial analysis of Lineage, Inc. (LINE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lineage, Inc., a leading company in the REIT – Industrial industry within the Real Estate sector.
- Taeyang Metal Industrial Co., Ltd. (004100.KS) Income Statement Analysis – Financial Results
- Satellos Bioscience Inc. (MSCL.TO) Income Statement Analysis – Financial Results
- EQ Health Acquisition Corp. (EQHA-UN) Income Statement Analysis – Financial Results
- Aspinwall and Company Limited (ASPINWALL.NS) Income Statement Analysis – Financial Results
- Rainbow Digital Commercial Co., Ltd. (002419.SZ) Income Statement Analysis – Financial Results
Lineage, Inc. (LINE)
About Lineage, Inc.
Lineage, Inc. engages in the provision of temperature-controlled warehouse real estate investment trust (REIT). It operates through the Global Warehousing and Global Integrated Solutions segments. The Global Warehousing segment composes of industrial real estate properties to provide temperature-controlled warehousing services to its customers. The Global Integrated Solutions segment consists of specialized cold-chain services. The company was founded in 2008 and is headquartered in Novi, MI.
Metric | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.34B | 4.93B | 3.70B | 517.82M | 826.68M | 917.71M | 2.88B | 4.98B | 2.33B | 1.77B | 1.62B | 772.28M | 4.38M | 12.85M | 15.54M |
Cost of Revenue | 3.59B | 3.47B | 2.57B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.75B | 1.46B | 1.13B | 517.82M | 826.68M | 917.71M | 2.88B | 4.98B | 2.33B | 1.77B | 1.62B | 772.28M | 4.38M | 12.85M | 15.54M |
Gross Profit Ratio | 32.73% | 29.53% | 30.54% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | -0.01 | -0.06 | 43.30M | 3.14M | 4.08M | 9.47M | 125.04M | 5.25M | 1.92M | 2.39M | 5.17M | 7.17M | 7.60M | 0.00 |
General & Administrative | 593.10M | 398.90M | 289.30M | 60.87M | 34.61M | 201.34M | 222.76M | 157.81M | 182.10M | 135.81M | 127.40M | 95.11M | 81.75M | 64.55M | 41.65M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 82.94M | 36.51M | 74.13M | 135.26M | 54.17M | 37.39M | 5.87M | 3.97M | 4.38M | 12.85M | 15.54M |
SG&A | 593.10M | 398.90M | 289.30M | 60.87M | 117.55M | 237.84M | 296.89M | 293.07M | 236.27M | 173.21M | 133.27M | 99.08M | 86.13M | 77.39M | 57.19M |
Other Expenses | 1.44B | 2.30M | 4.50M | 0.00 | 208.45M | 317.05M | 617.76M | 805.16M | 410.42M | 349.52M | 264.66M | 177.98M | 39.34M | 30.41M | 31.34M |
Operating Expenses | 2.03B | 1.08B | 893.00M | 104.18M | 329.13M | 558.97M | 924.12M | 1.22B | 651.94M | 524.64M | 400.32M | 282.22M | 132.65M | 115.40M | 88.53M |
Cost & Expenses | 5.62B | 4.55B | 3.46B | 293.28M | 69.46M | 1.41B | 7.81B | 4.83B | 2.59B | 1.76B | 816.42M | 613.74M | 132.65M | 115.40M | 88.53M |
Interest Income | 0.00 | 3.20M | 3.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 222.10M | 367.20M | 235.00M | 8.35M | 12.36M | 192.86M | 546.45M | 587.84M | 421.14M | 379.94M | 259.73M | 193.51M | 92.70M | 94.52M | 62.13M |
Depreciation & Amortization | 759.70M | 4.58B | 3.62B | 161.72M | 137.42M | 417.59M | 840.50M | 1.12B | 850.82M | 631.75M | 357.91M | 265.55M | 21.82M | 17.02M | 97.96M |
EBITDA | 452.00M | 1.06B | 841.00M | 386.30M | 971.59M | -1.55B | -3.38B | 1.27B | 578.42M | 627.86M | 1.06B | 349.01M | -179.45M | 1.11B | -207.83M |
EBITDA Ratio | 8.46% | 21.11% | 22.39% | 74.60% | 117.53% | -168.92% | -117.20% | 25.39% | 24.81% | 35.39% | 65.43% | 45.19% | -4,096.94% | 8,628.72% | -1,337.63% |
Operating Income | -281.20M | 297.30M | 87.70M | 224.54M | 741.61M | -374.50M | -4.77B | -447.37M | -691.34M | -386.62M | 438.44M | -110.05M | -295.84M | 825.66M | -360.78M |
Operating Income Ratio | -5.26% | 6.03% | 2.37% | 43.36% | 89.71% | -40.81% | -165.30% | -8.98% | -29.65% | -21.79% | 27.02% | -14.25% | -6,754.36% | 6,427.35% | -2,322.04% |
Total Other Income/Expenses | -248.60M | -367.30M | -293.50M | -8.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.22M | 2.71M | 0.00 |
Income Before Tax | -529.80M | -70.00M | -205.80M | 216.19M | 741.61M | -374.50M | -4.77B | -447.37M | -691.34M | -386.62M | 438.44M | -110.05M | -300.06M | 828.37M | -360.78M |
Income Before Tax Ratio | -9.92% | -1.42% | -5.56% | 41.75% | 89.71% | -40.81% | -165.30% | -8.98% | -29.65% | -21.79% | 27.02% | -14.25% | -6,850.73% | 6,448.46% | -2,322.04% |
Income Tax Expense | -45.40M | 6.00M | -29.30M | 356.90M | 388.94M | 11.19M | -6.46M | 4.44M | -2.20M | 2.79M | 5.47M | 4.24M | 4.22M | -2.71M | -3.57M |
Net Income | -437.10M | -62.70M | -153.30M | -140.67M | 432.86M | -2.17B | -4.76B | -451.81M | -691.34M | -386.62M | 438.44M | -114.29M | -298.19M | 999.62M | -364.35M |
Net Income Ratio | -8.18% | -1.27% | -4.14% | -27.17% | 52.36% | -236.66% | -165.08% | -9.07% | -29.65% | -21.79% | 27.02% | -14.80% | -6,808.04% | 7,781.54% | -2,345.04% |
EPS | -2.08 | -0.30 | -0.73 | -0.92 | 4.94 | -6.16 | -13.86 | -1.37 | -2.91 | -1.90 | 2.55 | -0.80 | -2.50 | 8.76 | -0.01 |
EPS Diluted | -2.08 | -0.30 | -0.73 | -0.92 | 4.88 | -6.16 | -13.86 | -1.37 | -2.91 | -1.90 | 2.54 | -0.80 | -2.50 | 8.75 | -0.01 |
Weighted Avg Shares Out | 210.20M | 210.80M | 210.80M | 152.23M | 87.65M | 352.65M | 343.32M | 328.92M | 237.54M | 203.78M | 172.00M | 142.54M | 119.31M | 114.14M | 68.92B |
Weighted Avg Shares Out (Dil) | 210.20M | 210.80M | 210.80M | 152.23M | 88.72M | 352.65M | 343.32M | 328.92M | 237.54M | 203.78M | 172.73M | 142.54M | 119.31M | 114.26M | 68.92B |
Rabobank Honors Lineage at Annual Leadership Summit
Ryp Labs Crowned the Winner of Lineage's 2024 Global Food Chain Innovation Challenge
Ryp Labs Crowned the Winner of Lineage's 2024 Global Food Chain Innovation Challenge
Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
Lineage Explores Connection Between Food Infrastructure and Economic Development in New Research by Economist Impact
NORWEGIAN CRUISE LINE® NAMES AWARD-WINNING ACTOR, ERIC STONESTREET, AS GODFATHER TO ITS NEWEST SHIP, NORWEGIAN AQUA™
Lineage price target lowered to $89 from $104 at Goldman Sachs
Top 4 Real Estate Stocks That May Rocket Higher In November
Lineage, Inc. (LINE) Q3 2024 Earnings Call Transcript
Lineage, Inc. Reports Third-Quarter 2024 Financial Results
Source: https://incomestatements.info
Category: Stock Reports